vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and IDACORP INC (IDA). Click either name above to swap in a different company.

IDACORP INC is the larger business by last-quarter revenue ($360.1M vs $191.2M, roughly 1.9× Axsome Therapeutics, Inc.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (57.4% vs -4.2%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (48.1% CAGR vs -7.2%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

AXSM vs IDA — Head-to-Head

Bigger by revenue
IDA
IDA
1.9× larger
IDA
$360.1M
$191.2M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+61.6% gap
AXSM
57.4%
-4.2%
IDA
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
48.1%
-7.2%
IDA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXSM
AXSM
IDA
IDA
Revenue
$191.2M
$360.1M
Net Profit
$43.6M
Gross Margin
Operating Margin
-33.1%
14.9%
Net Margin
12.1%
Revenue YoY
57.4%
-4.2%
Net Profit YoY
15.1%
EPS (diluted)
$0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
IDA
IDA
Q1 26
$191.2M
Q4 25
$196.0M
$360.1M
Q3 25
$171.0M
$526.4M
Q2 25
$150.0M
$449.3M
Q1 25
$121.5M
$411.1M
Q4 24
$118.8M
$375.9M
Q3 24
$104.8M
$532.5M
Q2 24
$87.2M
$442.6M
Net Profit
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
$-28.6M
$43.6M
Q3 25
$-47.2M
$124.4M
Q2 25
$-48.0M
$95.8M
Q1 25
$-59.4M
$59.6M
Q4 24
$-74.9M
$37.9M
Q3 24
$-64.6M
$113.6M
Q2 24
$-79.3M
$89.5M
Operating Margin
AXSM
AXSM
IDA
IDA
Q1 26
-33.1%
Q4 25
-13.8%
14.9%
Q3 25
-27.0%
27.5%
Q2 25
-24.5%
22.4%
Q1 25
-46.9%
13.4%
Q4 24
-61.1%
11.0%
Q3 24
-59.8%
25.1%
Q2 24
-89.5%
23.3%
Net Margin
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
-14.6%
12.1%
Q3 25
-27.6%
23.6%
Q2 25
-32.0%
21.3%
Q1 25
-48.9%
14.5%
Q4 24
-63.1%
10.1%
Q3 24
-61.7%
21.3%
Q2 24
-91.0%
20.2%
EPS (diluted)
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
$-0.55
$0.78
Q3 25
$-0.94
$2.26
Q2 25
$-0.97
$1.76
Q1 25
$-1.22
$1.10
Q4 24
$-1.54
$0.72
Q3 24
$-1.34
$2.12
Q2 24
$-1.67
$1.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
IDA
IDA
Cash + ST InvestmentsLiquidity on hand
$305.1M
$215.7M
Total DebtLower is stronger
$70.0M
$3.3B
Stockholders' EquityBook value
$3.6B
Total Assets
$713.6M
$10.2B
Debt / EquityLower = less leverage
0.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
IDA
IDA
Q1 26
$305.1M
Q4 25
$322.9M
$215.7M
Q3 25
$325.3M
$333.2M
Q2 25
$303.0M
$474.5M
Q1 25
$300.9M
$634.5M
Q4 24
$315.4M
$368.9M
Q3 24
$327.3M
$427.9M
Q2 24
$315.7M
$169.6M
Total Debt
AXSM
AXSM
IDA
IDA
Q1 26
$70.0M
Q4 25
$3.3B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Stockholders' Equity
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
$88.3M
$3.6B
Q3 25
$73.7M
$3.5B
Q2 25
$73.1M
$3.4B
Q1 25
$53.2M
$3.3B
Q4 24
$57.0M
$3.3B
Q3 24
$92.9M
$3.3B
Q2 24
$102.9M
$3.2B
Total Assets
AXSM
AXSM
IDA
IDA
Q1 26
$713.6M
Q4 25
$689.8M
$10.2B
Q3 25
$669.3M
$10.1B
Q2 25
$639.8M
$9.9B
Q1 25
$596.7M
$9.6B
Q4 24
$568.5M
$9.2B
Q3 24
$561.5M
$9.1B
Q2 24
$548.2M
$8.7B
Debt / Equity
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
0.93×
Q3 25
Q2 25
Q1 25
Q4 24
0.92×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
IDA
IDA
Operating Cash FlowLast quarter
$137.8M
Free Cash FlowOCF − Capex
$-216.2M
FCF MarginFCF / Revenue
-60.0%
Capex IntensityCapex / Revenue
98.3%
Cash ConversionOCF / Net Profit
3.16×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
$-18.7M
$137.8M
Q3 25
$1.0M
$162.8M
Q2 25
$-32.4M
$176.9M
Q1 25
$-43.4M
$124.3M
Q4 24
$-26.2M
$136.4M
Q3 24
$-18.6M
$201.9M
Q2 24
$-30.1M
$146.4M
Free Cash Flow
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
$-18.7M
$-216.2M
Q3 25
$988.0K
$-127.9M
Q2 25
$-32.4M
$-156.4M
Q1 25
$-43.7M
$-77.0M
Q4 24
$-26.2M
$-48.9M
Q3 24
$-18.7M
$-16.1M
Q2 24
$-30.2M
$-199.6M
FCF Margin
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
-9.6%
-60.0%
Q3 25
0.6%
-24.3%
Q2 25
-21.6%
-34.8%
Q1 25
-36.0%
-18.7%
Q4 24
-22.1%
-13.0%
Q3 24
-17.9%
-3.0%
Q2 24
-34.6%
-45.1%
Capex Intensity
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
0.0%
98.3%
Q3 25
0.0%
55.2%
Q2 25
0.0%
74.2%
Q1 25
0.3%
49.0%
Q4 24
0.0%
49.3%
Q3 24
0.1%
41.0%
Q2 24
0.1%
78.2%
Cash Conversion
AXSM
AXSM
IDA
IDA
Q1 26
Q4 25
3.16×
Q3 25
1.31×
Q2 25
1.85×
Q1 25
2.08×
Q4 24
3.60×
Q3 24
1.78×
Q2 24
1.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Product sales, net$189.4M99%
Royalty revenue and milestone revenue$1.8M1%

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

Related Comparisons